National Institutes of Health Grant for Therapeutic Agents Development (X01)

The National Institutes of Health is offering the Resource Access for the Bridging Interventional Development Gaps Program (X01) grant to provide in-kind services for researchers to bridge the gap between preclinical and clinical stages of therapy development. Through this Funding Opportunity Announcement (FOA), investigators can access government-funded contract resources necessary for the preclinical development of therapeutic agents. The grant aims to facilitate the translation of therapeutic discoveries into clinically-available agents to enhance the standard of care for patients with various diseases and disorders. Closing date for applications is April 3, 2012.

Opportunity ID: 141935

Apply

General Information

Document Type::	Grants Notice
Funding Opportunity Number::	PAR-12-092
Funding Opportunity Title::	Resource Access for the Bridging Interventional Development Gaps Program (X01)
Opportunity Category::	Discretionary
Opportunity Category Explanation::
Funding Instrument Type::
Category of Funding Activity::	Health
Category Explanation::
Expected Number of Awards::
Assistance Listings Number(s)::	93.310 — Trans-NIH Research Support
Cost Sharing or Matching Requirement::	No
Version::	Synopsis 1
Posted Date::	Feb 01, 2012
Last Updated Date::
Original Closing Date for Applications::	Apr 03, 2012
Current Closing Date for Applications::	Apr 03, 2012
Archive Date::	May 04, 2012
Estimated Total Program Funding::
Award Ceiling::	$
Award Floor::	$

Eligibility

Eligible Applicants::

Public housing authorities/Indian housing authorities

Additional Information on Eligibility::

Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.

Foreign components, as defined in theNIH Grants Policy Statement, are allowed.

Additional Information

Agency Name::	National Institutes of Health
Description::	The high cost of translating therapeutic discoveries into clinically-available agents can deter the development of promising therapeutics. When private sector resources are limited, BrIDGs in-kind services could help researchers span the gap between the preclinical and clinical stages of therapy development and continue to evaluate agents that may improve the standard of care for patients with a variety of diseases and disorders.The purpose of this Funding Opportunity Announcement (FOA) is to invite investigators to apply for access to government-funded contract resources needed for the preclinical development of therapeutic agents.
Link to Additional Information::
Grantor Contact Information::	If you have difficulty accessing the full announcement electronically, please contact:

Version History

Version	Modification Description	Updated Date
Synopsis 1

Package Status

Below are CLOSED Opportunity Package(s) no longer available for this Funding Opportunity:

Package No: 1

Assistance Listings:	93.310
Competition ID:	ADOBE-FORMS-B1
Competition Title:	ADOBE-FORMS-B1
Opportunity Package ID:	PKG00095651
Opening Date:	Mar 03, 2012
Closing Date:	Apr 03, 2012
Agency Contact Information::	Grants Info
Who Can Apply::	Organization Applicants
mendatory_forms	SF424 (R & R) [V1.2] PHS 398 Research Plan [V1.3] Research And Related Other Project Information [V1.3] PHS 398 Cover Page Supplement [V1.4] Research And Related Senior/Key Person Profile (Expanded) [V1.2]
optional_forms	PHS Cover Letter [V1.2]